Polaryx Therapeutics, Inc. engages in the manufacturing of biotechnology products. Its pipeline of products includes PLX-100, PLX-200, and PLX-300. The company was founded by Hahn-Jun Lee on August 22, 2014 and is headquartered in Paramus, NJ.
Sector:
Commercial Services
Industry:
Miscellaneous Commercial Services
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Polaryx Therapeutics Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Polaryx Therapeutics Inc. market cap is $151.03M.
What is the 52-week high for Polaryx Therapeutics Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Polaryx Therapeutics Inc. 52 week high is $48.91 as of February 28, 2026.
What is the 52-week low for Polaryx Therapeutics Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Polaryx Therapeutics Inc. 52 week low is $2.20 as of February 28, 2026.
What is Polaryx Therapeutics Inc. stock price today?
Polaryx Therapeutics Inc. stock price today is $3.05.
What was Polaryx Therapeutics Inc. stock price yesterday?
Polaryx Therapeutics Inc. stock price yesterday was $3.19.
What is the PE ratio of Polaryx Therapeutics Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Polaryx Therapeutics Inc.'s P/E ratio is -18.39.
What is the Price-to-Book ratio of Polaryx Therapeutics Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Polaryx Therapeutics Inc. P/B ratio is 28.4898.
What is the 50-day moving average of Polaryx Therapeutics Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Polaryx Therapeutics Inc. 50-day moving average is $7.87.
